Apnimed Announces Launch of Joint Venture with Shionogi to :

$150M transaction supporting early and clinical-stage pipeline development in OSA and related sleep disorders to find oral pharmacologic solutions for...

Related Keywords

United States , Japan , Cambridge , Cambridgeshire , United Kingdom , Americans , Wendy Gabel , Larry Miller , Apnimed Inc , Linkedin , Shionogi Co Ltd , Shionogi Apnimed Sleep Science , Apnimed Sleep Science , Chief Executive Officer , Sleep Apnea , Apnimed , Nc , Shionogi , Joint Venture , Obstructive Sleep Apnea , Sleep Disorders , Drug Discovery , Research , Clincial Trials ,